Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial

BACKGROUND: Bariatric surgery has adverse effects on the muscular-skeletal system with loss of bone mass and muscle mass and an increase in the risk of fracture. Zoledronic acid is widely used in osteoporosis and prevents bone loss and fracture. Bisphosphonates may also have positive effects on skel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gam, Søren, Gram, Bibi, Juhl, Claus Bogh, Hermann, Anne Pernille, Hansen, Stinus Gadegaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548152/
https://www.ncbi.nlm.nih.gov/pubmed/36209245
http://dx.doi.org/10.1186/s13063-022-06766-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548152/
https://www.ncbi.nlm.nih.gov/pubmed/36209245
http://dx.doi.org/10.1186/s13063-022-06766-z

Ejemplares similares